Food Safety Incidents

Ingredient that has not been evaluated with regard to food safety has been detected in Fantastic oat red fruits.

Written by SGS Digicomply Editorial Team | Feb 27, 2026 11:00:00 PM

Food Safety Alert: Ingredient Evaluation Concern

On February 12, 2026, a significant food safety incident was reported regarding a product identified as Fantastic oat red fruits. The Brazilian Health Regulatory Agency (ANVISA) has raised concerns after detecting an ingredient in this product that has not undergone proper evaluation for food safety.

This incident highlights the importance of rigorous safety assessments for all food products, particularly those that may contain unfamiliar or untested ingredients. Consumers are advised to be cautious and stay informed about the products they consume, especially those sourced from regions where regulatory oversight may vary.

The origin of the issue has been traced back to Brazil, emphasizing the need for comprehensive food safety regulations and monitoring systems to ensure that all food items in the market are safe for consumption. It is crucial for manufacturers to adhere to safety standards and for regulatory bodies to conduct thorough evaluations of all food ingredients.

As this situation develops, consumers should remain vigilant and consider checking for updates from health authorities regarding the safety of oat products and any potential recalls or advisories. Ensuring food safety is a shared responsibility among producers, regulators, and consumers alike.

  • Incident: Ingredient that has not been evaluated with regard to food safety has been detected in Fantastic oat red fruits.
  • Date: 2026-02-12
  • Product: Fantastic oat red fruits
  • Market: Available to SGS Digicomply users only. Explore the platform (for enterprises, no individual plans)
  • Origin of issue: Brazil
  • Hazard: Available to SGS Digicomply users only. Explore the platform (for enterprises, no individual plans)
  • Incident Category: Control
  • Source: Brazilian Health Regulatory Agency - ANVISA